Dr Maziar Navidi
Professor Alexander Phillips
Professor Michael Griffin
Professor Alastair Greystoke
Dr Kate Sumpter
et al. | Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer | 2018 |
|
Dr Kate Sumpter
| A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma | 2016 |
|
Professor Michael Griffin
Dr Kate Sumpter
| A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) +/- lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948) | 2016 |
|
Dr Kate Sumpter
| High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial | 2016 |
|
John Moir
Dr Peter Littler
Dr Kate Sumpter
Steven White
Jeremy French
et al. | Initial experience in irreversible electroporation for the treatment of locally advanced unresectable pancreatic cancer | 2016 |
|
Dr Maziar Navidi
Dr Kate Sumpter
Professor Michael Griffin
| Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy | 2016 |
|
Dr Rhona Sinclair
Dr Maziar Navidi
Professor Michael Griffin
Dr Kate Sumpter
| The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma | 2016 |
|
Dr Rachel Pearson
Elizabeth Howell
Dr Kate Sumpter
| 3 '-Deoxy-3 '-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer | 2015 |
|
Dr Fareeda Coxon
Dr Kate Sumpter
| Peri-operative chemotherapy +/- bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948) | 2015 |
|
Dr Jess Dyson
Dr Dipanker Chattopadhyay
Rajiv Lochan Jayadeva
Dr Imran Patanwala
Mike Cole
et al. | Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team | 2014 |
|
Dr Deborah Stocken
Dr Kate Sumpter
| Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study | 2014 |
|
